SHARE THIS VIDEO —
Pfizer releases new data from maternal RSV vaccine trials
NBC News Clone summarizes the latest on: Mmvo152144453707 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
Pfizer has released new data from its trials for a potential maternal vaccine against the common respiratory virus RSV that shows an 81 percent effectiveness against severe illness in the first 90 days of a newborn’s life. NBC News medical contributor Dr. Kavita Patel has the details.
Stay informed with daily digest and insights from NBC News Clone. We repackage top headlines for our global readers.
